Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-023-00492-8 |
ISSN: | 2397-768X |
---|